Indero is a specialized contract research organization (CRO) supporting clinical trials in dermatology and rheumatology, with a focus on immune-mediated diseases. Formerly known as Innovaderm on the CRO side of its business, the company draws on more than 25 years of clinical research experience. Innovaderm continues to operate as a dedicated dermatology clinical research unit.

Indero provides end-to-end trial delivery for biotech and pharmaceutical sponsors, covering early-phase and translational research through late-phase studies. Its services include study design and protocol writing, site selection and management, patient recruitment, clinical monitoring, project management, medical monitoring, pharmacovigilance, quality assurance, medical writing, regulatory and clinical development consulting, and biostatistics and data management.

The company supports a broad range of conditions, including psoriasis, atopic dermatitis, alopecia areata, rheumatoid arthritis, lupus, and systemic sclerosis. Its global operational capabilities span North America, Europe, Latin America, and Asia-Pacific, supported by an international investigator network. Indero combines therapeutic expertise and clinical experience to help sponsors build rigorous studies, generate quality data, and deliver trials efficiently.